Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health
By Natalie Grover

Bavarian Nordic in talks to expand monkeypox vaccine output

FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth

Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said on Monday.

The Copenhagen-based vaccine maker has a product with the brand name Jynneos, Imvamune or Imvanex depending on geography and which has U.S. and European approval to protect against monkeypox.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.